In addition, no differences in WIF1 promoter methylation levels were found between GC cases and controls in this study, while previous reports have shown WIF1 hypermethylation in circulating DNA of colorectal cancer patients [38, 39] and in tissue-derived DNA of several types of tumours, including GC [20]. This evidence concerns the gene WIF1 and neoplasm.